OPKO Health (Ireland) and Entera Bio Ltd. collaborated on the development of an oral GLP-2 analog therapy.
2 reports, 1 independent
Updated Jul 23
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
OPKO Health (Ireland) and Entera Bio Ltd. collaborated on the development of an oral GLP-2 analog therapy.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
OPKO Health (Ireland)
company in Waterford, Ireland
Nothing else this week.
Coverage
Newest first; wire copies grouped- Insider MonkeyOPKO Health’s (OPK) Oral GLP-2 Analog Selected for a Poster Presentation in Collaboration with Entera Bio (ENTX) OPKO Health, Inc. (NASDAQ:OPK) is one of the Best American Penny Stocks to Buy Accordi
- Unknown outlet